Cefonicid monosodium salt is a pharmaceutical compound that belongs to the cephalosporin class of antibiotics. It is a derivative of cephalosporin C and is known for its broad spectrum of activity against various bacterial strains.
This compound is prepared by adding a sodium salt to cefonicid, a semi-synthetic, bactericidal antibiotic derived from cephalosporin C. The addition of the monosodium salt increases the solubility and bioavailability of the compound, allowing for easier administration and absorption in the body.
Cefonicid monosodium salt works by inhibiting the synthesis of the bacterial cell wall, disrupting its integrity and leading to bacterial cell death. It is effective against a wide range of gram-positive and gram-negative bacteria, including strains that are resistant to other classes of antibiotics.
Due to its ability to penetrate well into bodily tissues and its stability against various bacterial enzymes, cefonicid monosodium salt exhibits a prolonged therapeutic effect. It is commonly used in the treatment of infections caused by susceptible organisms, such as respiratory tract infections, urinary tract infections, skin and soft tissue infections, and bone and joint infections.
As with any antibiotic, cefonicid monosodium salt should be used judiciously and under medical supervision to avoid bacterial resistance and the occurrence of side effects. Common side effects may include diarrhea, nausea, vomiting, and allergic reactions.
